Autolus Therapeutics Ltd | AUTL - Operating Profit

Stock Price
1.63
Daily Change
0.04 2.52%
Monthly
1.24%
Yearly
22.56%
Q2 Forecast
1.60

Autolus Therapeutics Ltd reported $-59.51M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
AstraZeneca USD 7.11B 4.14B Mar/2026
Autolus Therapeutics Ltd USD -59.51M 12.95M Mar/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Novartis USD 4.24B 171M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Silence Therapeutics USD -12.46M 13.78M Dec/2025